Pantherics Incorporated, a UWM startup company received a $255,841 Phase I Small Business Innovation Research (SBIR) grant from the National Institutes of Health (NIH), National Heart, Lung, and Blood Institute, to advance development of a fundamentally novel anti-inflammatory drug, with… Read More
The UWM Research Foundation has awarded “Bradley Catalyst” funding to Prof. Frick to evaluate new lead compound EGX854, which has demonstrated greater selectivity and 4-fold better potency. EGX854 has also shown potential for better brain penetration. Dr. Frick will evaluated… Read More
After a successful fund raising campaign, local startup company Estrigenix has engaged the MIDD to conduct pre-clinical characterization of their lead compounds. Estrigenix Therapeutics was formed in 2018 as a spin out from a collaboration research of three Milwaukee area… Read More
Milwaukee startup company Function Therapeutics moves to the Chemistry Department at UWM to conduct their R&D. The company is led by Dr. Chris Dockendorff (formerly Marquette Chemistry faculty), and is focused on the medicinal chemistry of a new class of… Read More
The University of Wisconsin Research Foundation’s Bridge Grant Program bolsters efforts to commercialize innovations developed at the UWM and foster development of startup companies that improve the Wisconsin economy. The program leverages a grant from the Wisconsin Economic Development Corporation… Read More
“The assistantship has helped me and my team (undergraduate students Jermarcus Lewis and Ranjak Joshi) to make significant scientific process towards my graduate work” said graduate student Ethan Kub. I was able to quantify ceramide levels in the U87 cells,… Read More
Simmaron Research Inc (SRI), a non-profit organization based in Incline Village, Nevada has recently moved some R&D work to UWM to take advantage of available vivarium space and to collaborate with the MIDD. SRI finds it roots in the medical… Read More
Even with significant COVID-19 restriction, we were able to come together on the 18th of January to showcase the cutting edge science that is part of the Milwaukee Institute for Drug Discovery. The hybrid format enabled online followers of the… Read More
Graduate Student Michelle Meyer has been selected by MIDD members based on scientific merit and potential to accelerate the development of new asthma drug candidates. Michelle is a member of the Arnold research group and will continue to work with… Read More
The MIDD has welcomed Anna Benko as new member. Dr. Benko is the Manager of SAILARC, the UWM mass spectrometry facility located in the Kenwood IRC. Dr. Benko received her PhD from UWM and worked at Sterling Pharma (Former Cambridge… Read More